FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096079 [Registered on: 14/10/2025] Trial Registered Prospectively
Last Modified On: 14/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study to assess if addition of a new device like nasopharyngeal airways has any effect in incidence of hypoxemia (low oxygen saturation) 
Scientific Title of Study   Comparison of the incidence of hypoxemia during sedated gastrointestinal endoscopy: Nasopharyngeal airway with nasal cannula versus nasal cannula alone : A randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Varsha Balachandran 
Designation  Post Graduate Student 
Affiliation  Armed Forces Medical College 
Address  Department of Anaesthesiology Armed Forces Medical College Wanowrie Pune Maharashtra

Pune
MAHARASHTRA
411040
India 
Phone  8056260997  
Fax    
Email  vakrish.1412@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Gunjan Singh 
Designation  Professor 
Affiliation  Armed Forces Medical College 
Address  Department of Anaesthesiology Armed Forces Medical College Wanowrie Pune Maharashtra

Pune
MAHARASHTRA
411040
India 
Phone  9612112136  
Fax    
Email  gunjanafmc@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Gunjan Singh 
Designation  Professor 
Affiliation  Armed Forces Medical College 
Address  Department of Anaesthesiology Armed Forces Medical College Wanowrie Pune Maharashtra

Pune
MAHARASHTRA
411040
India 
Phone  9612112136  
Fax    
Email  gunjanafmc@gmail.com  
 
Source of Monetary or Material Support  
Armed Forces Medical College 
 
Primary Sponsor  
Name  Varsha Balachandran 
Address  Department of Anaesthesiology Armed Forces Medical College Wanowrie Pune Maharashtra 411040 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Varsha Balachandran  Command Hospital Southern Command  Endoscopy Suite Command Hospital Southern Command Pune Cantonment
Pune
MAHARASHTRA 
8056260997

vakrish.1412@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Armed Forces Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z038||Encounter for observation for other suspected diseases and conditions ruled out,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nasal cannula  Patients receive oxygen via only nasal cannula 
Intervention  nasopharyngeal airway and nasal cannula  Patients receive oxygen via nasopharyngeal airway and nasal cannula 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Patients undergoing gastrointestinal endoscopy
Patients accepted in ASA classification I to III 
 
ExclusionCriteria 
Details  History of upper respiratory tract infection in the past two weeks

Severe chronic obstructive pulmonary disease or acute attack of asthma

Baseline oxygen saturation less than 90% when inhaling air

History of allergy to eggs, soy, albumin or sedatives

Nasal obstruction and cannot effectively inhale oxygen through the nose

Congenital anomalies affecting the anatomy of the airways

Pregnancy or lactation

Glaucoma
 
 
Method of Generating Random Sequence   Permuted block randomization, variable 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome will be the incidence of hypoxemia during the procedure, defined as SPO2 less than 90. Hypoxemia will be considered clinically significant if the duration of low SPO2 exceeds 1 minute.  From induction of sedation to the end of the gastrointestinal endoscopy procedure 
 
Secondary Outcome  
Outcome  TimePoints 
Any additional measures required to manage hypoxemia, such as increasing oxygen flow or manual ventilation, will be recorded and record adverse events related to sedation or the use of the NPA   From induction of sedation to the end of the gastrointestinal endoscopy procedure 
 
Target Sample Size   Total Sample Size="188"
Sample Size from India="188" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   30/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Gastrointestinal endoscopy, a widely performed diagnostic and therapeutic procedure, is often done under sedation. However, sedation can lead to respiratory depression and hypoxemia, a condition where blood oxygen levels fall below normal. Although oxygen supplementation using nasal cannulas is common practice, it may not be sufficient to prevent hypoxemia in some patients. The nasopharyngeal airway (NPA) is a device that may provide an airway for oxygenation comparable to standard nasal cannula delivery during gastrointestinal endoscopy with sedation. The present study will determine whether the addition of the NPA offers significant advantages in preventing hypoxemia by comparing outcomes between patients receiving standard oxygen delivery (standard nasal cannula) and those receiving oxygen via both a standard nasal cannula and an NPA.

 
Close